Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Russell

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Nature Communications|May 24, 2020
An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cellsMaikel L Colli, Mireia Ramos-Rodríguez, Ernesto S Nakayasu, et al.
Bioorganic & Medicinal Chemistry|March 28, 2007
Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimizationSrinivasan R Nagarajan, Hwang-Fun Lu, Alan F Gasiecki, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
R-isomers of Arg-Gly-Asp (RGD) mimics as potent alphavbeta3 inhibitorsSrinivasan R Nagarajan, Balekudru Devadas, James W Malecha, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonistsMark L Boys, Lori A Schretzman, Nizal S Chandrakumar, et al.
The Journal of Allergy and Clinical Immunology|October 13, 2022
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndromeJennifer W Leiding, Tiphanie P Vogel, Valentine G J Santarlas, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Nature Communications|May 24, 2020
An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cellsMaikel L Colli, Mireia Ramos-Rodríguez, Ernesto S Nakayasu, et al.
Bioorganic & Medicinal Chemistry|March 28, 2007
Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimizationSrinivasan R Nagarajan, Hwang-Fun Lu, Alan F Gasiecki, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
R-isomers of Arg-Gly-Asp (RGD) mimics as potent alphavbeta3 inhibitorsSrinivasan R Nagarajan, Balekudru Devadas, James W Malecha, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonistsMark L Boys, Lori A Schretzman, Nizal S Chandrakumar, et al.
The Journal of Allergy and Clinical Immunology|October 13, 2022
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndromeJennifer W Leiding, Tiphanie P Vogel, Valentine G J Santarlas, et al.
Pageof 8